Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
OTC Markets
ETFs
Canadian ETFs
US ETFs
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cardiol Therapeutics Inc.
T.CRDL
Alternate Symbol(s):
CRDL
|
T.CRDL.W.A
Healthcare
Drug Manufacturers - Specialty & Generic
Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct...
clinical studies to evaluate the efficacy and safety of CardiolRx¿ in two diseases affecting the heart: (i) a Phase II multi-center open-label pilot study in recurrent pericarditis (inflammation of the pericardium), which is associated with symptoms including debilitating chest pain, shortness of breath, and fatigue, and results in physical limitations, reduced quality of life, emergency department visits, and hospitalizations; and (ii) a Phase II multi-national, randomized, double-blind, placebo-controlled trial (the ¿ARCHER¿ trial) in acute myocarditis, an important cause of acute and fulminant heart failure in young adults and a leading cause of sudden cardiac death in people less than 35 years of age.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CRDL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(151)
•••
Bubula50
X
Post by
Bubula50
on Jun 06, 2023 11:42am
Financially healthy also
Return vs Industry: CRDL exceeded the Canadian Pharmaceuticals industry which returned -55.8% over the past year.
(151)
•••
Bubula50
X
Post by
Bubula50
on Jun 06, 2023 11:37am
In again
You should never fall in love with stocks but Crdl is one of my faves and at this price it is a steal imo
Cedar Clinical Research, by Numinus, the top enrolling clinical research site for MindMed's Phase 2B study evaluating MM-120
posted Jun 06, 2023 9:00am by
Numinus Wellness Inc.
-
|
"We're excited to support MindMed in their clinical trial work, by evaluating new important treatments and protocols to address mental health disorders...The fact that our Draper research clinic is the top enrolling site for the study underscores the quality of our clinical research capabilities and recruiting efforts ...read more
(54)
•••
Bullknit101
X
Post by
Bullknit101
on May 24, 2023 11:02pm
CBD Study Dr. Campbell
https://youtu.be/Bz4fn2QFO_A
(54)
•••
Bullknit101
X
Post by
Bullknit101
on Feb 25, 2023 9:29am
Cardiol Presentation - Undervalued Stock
https://youtu.be/ER9ke3YbFUU
(54)
•••
Bullknit101
X
Post by
Bullknit101
on Feb 25, 2023 9:26am
Keep an Eye on this One
https://www.cantechletter.com/2022/12/cardiol-therapeutics-is-heading-to-4-50-says-leede-jones-gable/
(54)
•••
Bullknit101
X
Post by
Bullknit101
on Jan 20, 2023 7:29am
Positive News Price Reversal
The worm also turned on Cardiol. With Orphan drug candidate and Phase 2 news, the SP has reversed and is started an uptrend finally. https://simplywall.st/stocks/ca/pharmaceuticals-biotech/tsx
...more
(3)
•••
bullmarketnow
X
Post by
bullmarketnow
on Dec 10, 2022 4:26pm
price action
Anyone knows why the sudden rebound?
(6)
•••
NorthBuddy
X
Post by
NorthBuddy
on Nov 11, 2022 5:32pm
Peeps liked the filing
The boys is doing it, https://quantisnow.com/insight/3668667 https://www.youtube.com/watch?v=bQDC_wuJ6j0&ab_channel=TBILISELICOLCHI
Thematica Insights Report and Investor Guide
Beyond Precious
An investor's guide to precious metals and their potential in today's market. Click here to access the report.
Jocelyn Aspa
6 June 2023 09:00
(6)
•••
NorthBuddy
X
Comment by
NorthBuddy
on Nov 10, 2022 9:18am
RE:0.68cents wild
Never say never Hun: https://online-calculator.org/stock-average-calculator.aspx
(21)
•••
Hundo22
X
Post by
Hundo22
on Nov 09, 2022 6:53pm
0.68cents wild
sorry for the folks that bought shares at 4 bucks. Seems like alot of people lost money on this one
(36)
•••
Mapleleaf57
X
Comment by
Mapleleaf57
on Nov 03, 2022 8:54am
RE:Bought more Cardiol today
I can't resist,, Jordan you pumper, September October has come and gone
(8)
•••
Jordan1159
X
Post by
Jordan1159
on Aug 17, 2022 8:44pm
Bought more Cardiol today
Couldn't resist. September is coming. Bounce incoming
(2)
•••
PattyMiller
X
Post by
PattyMiller
on Aug 02, 2022 2:26pm
I’m back! Party coming soon?
I think once everyone gets back to work end of August into September, we will see a surge in the price of our shares. I bought more here last week. I am very hopeful what cardio will be able to do if
...more
(8)
•••
Jordan1159
X
Comment by
Jordan1159
on Jul 22, 2022 7:11am
RE:RE:This will recover. Hang tight IMHO
No pump here, I just like the company and what they are doing. I see the potential. Hope you're not shorting this as you may find yourself covering at much higher share price levels. Get positive
...more
(36)
•••
Mapleleaf57
X
Comment by
Mapleleaf57
on Jul 19, 2022 8:00pm
RE:This will recover. Hang tight IMHO
Yup.. keep on pumping,,,,
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video
{{moreVideoText}}
Next Video >
Featured News Links
Rapid Expansion of Dehydratech into USA Cannabis Markets Leads to Rapid Revenue Growth
Will 2023 be a Record-Breaking Year for Precious Metal Prices? – Experts insight available here
Full Circle Lithium Makes Significant Advancing in their Lithium Recycling Demo Plant Buildout and Related Technology